Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 3 Neoplasm Metastasis 3 Advanced Malignant Solid Tumors 3 Thrombocytosis 1 Stomach Neoplasms 1 Solid Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Blast Crisis 1 Anemia 1

Interventions

Paclitaxel 68 Carboplatin 64 pembrolizumab 32 Cyclophosphamide 32 Bevacizumab 27 liposomal doxorubicin 24 Cisplatin 24 Topotecan 21 Gemcitabine 21 olaparib 18 fludarabine 17 Taxes 16 Docetaxel 15 Nivolumab 14 Doxorubicin 14 niraparib 13 veliparib 12 Albumin-Bound Paclitaxel 11 aldesleukin 9 Filgrastim 9 fludarabine phosphate 8 durvalumab 8 Oxaliplatin 8 Fluorouracil 8 Drug Therapy 8 sargramostim 7 Peripheral Blood Stem Cell Transplantation 7 Magnetic Resonance Spectroscopy 7 Leucovorin 7 talazoparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Ovarian Neoplasms × neratinib × Clear all

NCT04502602 2026-05-11

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡